{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:23:15Z","timestamp":1790900595433,"version":"4.1.0"},"reference-count":90,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T00:00:00Z","timestamp":1629244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008730","name":"Kreftforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008730","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Forskningsr\u00e5det","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Colorectal cancer (CRC) screening reduces CRC incidence and mortality. However, current screening methods are either hampered by invasiveness or suboptimal performance, limiting their effectiveness as primary screening methods. To aid in the development of a non-invasive screening test with improved sensitivity and specificity, we have initiated a prospective biomarker study (CRCbiome), nested within a large randomized CRC screening trial in Norway. We aim to develop a microbiome-based classification algorithm to identify advanced colorectal lesions in screening participants testing positive for an immunochemical fecal occult blood test (FIT). We will also examine interactions with host factors, diet, lifestyle and prescription drugs. The prospective nature of the study also enables the analysis of changes in the gut microbiome following the removal of precancerous lesions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The CRCbiome study recruits participants enrolled in the Bowel Cancer Screening in Norway (BCSN) study, a randomized trial initiated in 2012 comparing once-only sigmoidoscopy to repeated biennial FIT, where women and men aged 50\u201374\u2009years at study entry are invited to participate. Since 2017, participants randomized to FIT screening with a positive test result have been invited to join the CRCbiome study. Self-reported diet, lifestyle and demographic data are collected prior to colonoscopy after the positive FIT-test (baseline). Screening data, including colonoscopy findings are obtained from the BCSN database. Fecal samples for gut microbiome analyses are collected both before and 2 and 12\u2009months after colonoscopy. Samples are analyzed using metagenome sequencing, with taxonomy profiles, and gene and pathway content as primary measures. CRCbiome data will also be linked to national registries to obtain information on prescription histories and cancer relevant outcomes occurring during the 10\u2009year follow-up period.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The CRCbiome study will increase our understanding of how the gut microbiome, in combination with lifestyle and environmental factors, influences the early stages of colorectal carcinogenesis. This knowledge will be crucial to develop microbiome-based screening tools for CRC. By evaluating biomarker performance in a screening setting, using samples from the target population, the generalizability of the findings to future screening cohorts is likely to be high.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\">ClinicalTrials.gov<\/jats:ext-link>\n                      Identifier:\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01538550\">NCT01538550<\/jats:ext-link>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-021-08640-8","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T05:02:59Z","timestamp":1629262979000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["The CRCbiome study: a large prospective cohort study examining the role of lifestyle and the gut microbiome in colorectal cancer screening participants"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6247-7304","authenticated-orcid":false,"given":"Ane S\u00f8rlie","family":"Kv\u00e6rner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Einar","family":"Birkeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilie","family":"Bucher-Johannessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3556-1118","authenticated-orcid":false,"given":"Elina","family":"Vinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan Inge","family":"Nordby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harri","family":"Kangas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Bemanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6072-0489","authenticated-orcid":false,"given":"Pekka","family":"Ellonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-8068","authenticated-orcid":false,"given":"Edoardo","family":"Botteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Natvig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9329-9974","authenticated-orcid":false,"given":"Torbj\u00f8rn","family":"Rognes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9103-1077","authenticated-orcid":false,"given":"Eivind","family":"Hovig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9870-6375","authenticated-orcid":false,"given":"Ole Herman","family":"Ambur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0273-3166","authenticated-orcid":false,"given":"Willem M.","family":"de Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Bultman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Hjart\u00e5ker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6399-7608","authenticated-orcid":false,"given":"Rikard","family":"Landberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1324-0316","authenticated-orcid":false,"given":"Mingyang","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4890-7555","authenticated-orcid":false,"given":"Hege Salvesen","family":"Blix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0835-9507","authenticated-orcid":false,"given":"Giske","family":"Ursin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin Ranheim","family":"Randel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3989-7487","authenticated-orcid":false,"given":"Thomas","family":"de Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0118-6818","authenticated-orcid":false,"given":"Geir","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind","family":"Holme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9025-4455","authenticated-orcid":false,"given":"Paula","family":"Berstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2677-2722","authenticated-orcid":false,"given":"Trine B.","family":"Rounge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,18]]},"reference":[{"key":"8640_CR1","doi-asserted-by":"crossref","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","DOI":"10.3322\/caac.21492"},{"key":"8640_CR2","first-page":"1","volume":"351","author":"DA Ouakrim","year":"2015","unstructured":"Ouakrim DA, Pizot C, Boniol M, Malvezzi M, Boniol M, Negri E, et al. Trends in colorectal cancer mortality in Europe: retrospective analysis of the WHO mortality database. BMJ. 2015;351:1\u201310.","journal-title":"BMJ."},{"issue":"12","key":"8640_CR3","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/S2468-1253(19)30345-0","volume":"4","author":"S Safiri","year":"2019","unstructured":"Safiri S, Sepanlou SG, Ikuta KS, Bisignano C, Salimzadeh H, Delavari A, et al. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990\u20132017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol. 2019;4(12):913\u201333. https:\/\/doi.org\/10.1016\/S2468-1253(19)30345-0.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8640_CR4","unstructured":"Danckert B, Ferlay J, Engholm G , Hansen HL, Johannesen TB, Khan S, et al. NORDCAN: Cancer Incidence, Mortality, Prevalence and Survival in the Nordic Countries. Version 8.2. 2019."},{"key":"8640_CR5","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Brest A, Yu M, et al (eds). SEER Cancer Statistics Review, 1975\u20132017, National Cancer Institute., Bethesda, MD, https:\/\/seer.cancer.gov\/csr\/1975_2017\/, based on November 2019 SEER data submission, posted to the SEER web site, April 2020. 2020."},{"key":"8640_CR6","doi-asserted-by":"crossref","unstructured":"Sung H, Siegel RL, Rosenberg PS, Jemal A. Emerging cancer trends among young adults in the USA: analysis of a population-based cancer registry. Lancet Public Heal. 2019;4:e137\u201347.","DOI":"10.1016\/S2468-2667(18)30267-6"},{"issue":"7","key":"8640_CR7","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/S2468-1253(19)30147-5","volume":"4","author":"M Araghi","year":"2019","unstructured":"Araghi M, Soerjomataram I, Bardot A, Ferlay J, Cabasag CJ, Morrison DS, et al. Changes in colorectal cancer incidence in seven high-income countries: a population-based study. Lancet Gastroenterol Hepatol. 2019;4(7):511\u20138. https:\/\/doi.org\/10.1016\/S2468-1253(19)30147-5.","journal-title":"Lancet Gastroenterol Hepatol."},{"issue":"6","key":"8640_CR8","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1053\/j.gastro.2009.12.066","volume":"138","author":"B Leggett","year":"2010","unstructured":"Leggett B, Whitehall V. Role of the serrated pathway in colorectal Cancer pathogenesis. Gastroenterology. 2010;138(6):2088\u2013100. https:\/\/doi.org\/10.1053\/j.gastro.2009.12.066. .","journal-title":"Gastroenterology."},{"key":"8640_CR9","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","volume":"394","author":"E Dekker","year":"2019","unstructured":"Dekker E, Tanis PJ, Vleugels JLA, Kasi PM, Wallace MB. Colorectal cancer. Lancet (London, England). 2019;394:1467\u201380 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31631858. .","journal-title":"Lancet (London, England)"},{"key":"8640_CR10","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1001\/jama.2016.5989","volume":"315","author":"K Bibbins-Domingo","year":"2016","unstructured":"Bibbins-Domingo K, Grossman DC, Curry SJ, Davidson KW, Epling JW, Garc\u00eda FAR, et al. Screening for colorectal cancer: US preventive services task force recommendation statement. JAMA - J Am Med Assoc. 2016;315:2564\u201375.","journal-title":"JAMA - J Am Med Assoc."},{"key":"8640_CR11","volume-title":"von Karsa L EC. European guidelines for quality Assurance in Colorectal Cancer Screening and Diagnosis - first edition","author":"N Segnan","year":"2010","unstructured":"Segnan N, Patnick J. von Karsa L EC. European guidelines for quality Assurance in Colorectal Cancer Screening and Diagnosis - first edition. Luxembourg: Office for Official Publications of the European Communities; 2010."},{"key":"8640_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40985-018-0080-0","volume":"39","author":"MH Ebell","year":"2018","unstructured":"Ebell MH, Thai TN, Royalty KJ. Cancer screening recommendations: an international comparison of high income countries. Public Health Rev. 2018;39:1\u201319.","journal-title":"Public Health Rev"},{"issue":"1","key":"8640_CR13","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1136\/gutjnl-2013-306503","volume":"64","author":"JJY Sung","year":"2015","unstructured":"Sung JJY, Ng SC, Chan FKL, Chiu HM, Kim HS, Matsuda T, et al. An updated Asia Pacific consensus recommendations on colorectal cancer screening. Gut. 2015;64(1):121\u201332. https:\/\/doi.org\/10.1136\/gutjnl-2013-306503.","journal-title":"Gut."},{"key":"8640_CR14","doi-asserted-by":"publisher","unstructured":"Atkin W, Wooldrage K, Parkin DM, Kralj-Hans I, MacRae E, Shah U, et al. Long term effects of once-only flexible sigmoidoscopy screening after 17 years of follow-up: the UK Flexible Sigmoidoscopy Screening randomised controlled trial. Lancet. 2017;389:1299\u20131311. https:\/\/doi.org\/10.1016\/S0140-6736(17)30396-3 Accessed 8 June 2021.","DOI":"10.1016\/S0140-6736"},{"issue":"25","key":"8640_CR15","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1056\/NEJMoa1114635","volume":"366","author":"R Schoen","year":"2012","unstructured":"Schoen R, Pinsky P, Weissfeld J, Yokochi L, Church T, Laiyemo A, et al. Colorectal-Cancer incidence and mortality with screening flexible sigmoidoscopy. N Engl J Med. 2012;366(25):2345\u201357. https:\/\/doi.org\/10.1056\/NEJMoa1114635.","journal-title":"N Engl J Med"},{"issue":"17","key":"8640_CR16","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1093\/jnci\/djr284","volume":"103","author":"N Segnan","year":"2011","unstructured":"Segnan N, Armaroli P, Bonelli L, Risio M, Sciallero S, Zappa M, et al. Once-only sigmoidoscopy in colorectal cancer screening: follow-up findings of the italian randomized controlled trial - SCORE. J Natl Cancer Inst. 2011;103(17):1310\u201322. https:\/\/doi.org\/10.1093\/jnci\/djr284.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"8640_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1001\/jama.2014.8266","volume":"312","author":"\u00d8 Holme","year":"2014","unstructured":"Holme \u00d8, L\u00f8berg M, Kalager M, Bretthauer M, Hern\u00e1n MA, Aas E, et al. Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial. JAMA - J Am Med Assoc. 2014;312(6):606\u201315. https:\/\/doi.org\/10.1001\/jama.2014.8266.","journal-title":"JAMA - J Am Med Assoc"},{"key":"8640_CR18","doi-asserted-by":"crossref","unstructured":"Mandel J, Bond J, Church T, Snover D, Bradley M, Schuman L, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;","DOI":"10.1056\/NEJM199305133281901"},{"key":"8640_CR19","doi-asserted-by":"publisher","unstructured":"Kronborg O, Fenger C, Olsen J, J\u00f8rgensen OD, S\u00f8ndergaard O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet. 1996;348(9040):1467\u201371. https:\/\/doi.org\/10.1016\/S0140-6736(96)03430-7. .","DOI":"10.1016\/S0140-6736"},{"issue":"8","key":"8640_CR20","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1002\/bjs.6136","volume":"95","author":"E Lindholm","year":"2008","unstructured":"Lindholm E, Brevinge H, Haglind E. Survival benefit in a randomized clinical trial of faecal occult blood screening for colorectal cancer. Br J Surg England. 2008;95(8):1029\u201336. https:\/\/doi.org\/10.1002\/bjs.6136.","journal-title":"Br J Surg England"},{"key":"8640_CR21","doi-asserted-by":"publisher","unstructured":"Hardcastle JD, Chamberlain JO, Robinson MHE, Moss SM, Amar SS, Balfour TW, et al. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348(9040):1472\u20137. https:\/\/doi.org\/10.1016\/S0140-6736(96)03386-7. .","DOI":"10.1016\/S0140-6736"},{"key":"8640_CR22","doi-asserted-by":"publisher","unstructured":"Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for Colorectal Cancer Screening. Gastroenterology [Internet]. Elsevier, Inc; 2020;158:418. https:\/\/doi.org\/10.1053\/j.gastro.2019.06.043. .","DOI":"10.1053\/j.gastro.2019.06.043"},{"issue":"10","key":"8640_CR23","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1136\/gutjnl-2014-309086","volume":"64","author":"EH Schreuders","year":"2015","unstructured":"Schreuders EH, Ruco A, Rabeneck L, Schoen RE, Sung JJY, Young GP, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64(10):1637\u201349. https:\/\/doi.org\/10.1136\/gutjnl-2014-309086.","journal-title":"Gut."},{"issue":"11","key":"8640_CR24","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.1038\/bjc.2011.160","volume":"104","author":"U Haug","year":"2011","unstructured":"Haug U, Kuntz KM, Knudsen AB, Hundt S, Brenner H. Sensitivity of immunochemical faecal occult blood testing for detecting left-vs right-sided colorectal neoplasia. Br J Cancer. 2011;104(11):1779\u201385. https:\/\/doi.org\/10.1038\/bjc.2011.160. .","journal-title":"Br J Cancer"},{"issue":"11","key":"8640_CR25","doi-asserted-by":"publisher","first-page":"775","DOI":"10.7326\/M17-1441","volume":"168","author":"\u00d8 Holme","year":"2018","unstructured":"Holme \u00d8, L\u00f8berg M, Kalager M, Bretthauer M, Hern\u00e1n MA, Aas E, et al. Long-term effectiveness of sigmoidoscopy screening on colorectal cancer incidence and mortality in women and men: a randomized trial. Ann Intern Med. 2018;168(11):775\u201382. https:\/\/doi.org\/10.7326\/M17-1441.","journal-title":"Ann Intern Med"},{"key":"8640_CR26","doi-asserted-by":"publisher","first-page":"381","DOI":"10.2147\/CLEP.S155548","volume":"10","author":"H Brenner","year":"2018","unstructured":"Brenner H, Qian J, Werner S. Variation of diagnostic performance of fecal immunochemical testing for hemoglobin by sex and age: results from a large screening cohort. Clin Epidemiol. 2018;10:381\u20139. https:\/\/doi.org\/10.2147\/CLEP.S155548.","journal-title":"Clin Epidemiol"},{"key":"8640_CR27","doi-asserted-by":"crossref","unstructured":"Tilg H, Adolph TE, Gerner RR, Moschen AR. The Intestinal Microbiota in Colorectal Cancer. Cancer Cell. Elsevier Inc.; 2018;33:954\u2013964.","DOI":"10.1016\/j.ccell.2018.03.004"},{"issue":"2","key":"8640_CR28","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1101\/gr.126573.111","volume":"22","author":"AD Kostic","year":"2012","unstructured":"Kostic AD, Gevers D, Pedamallu CS, Michaud M, Duke F, Earl AM, et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res. 2012;22(2):292\u20138. https:\/\/doi.org\/10.1101\/gr.126573.111.","journal-title":"Genome Res"},{"issue":"2","key":"8640_CR29","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1101\/gr.126516.111","volume":"22","author":"M Castellarin","year":"2012","unstructured":"Castellarin M, Warren R, Freeman J, Dreolini L, Krzywinski M, Strauss J, et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res. 2012;22(2):299\u2013306. http:\/\/www.embase.com\/search\/results?subaction=viewrecord&from=export&id=L364186952%5Cnhttp:\/\/genome.cshlp.org\/content\/22\/2\/299.full.pdf+html%5Cnhttp:\/\/dx.doi.org\/10.1101\/gr.126516.111%5Cnhttp:\/\/sfx.library.uu.nl\/utrecht?sid=EMBASE&issn=10889051&id=doi:10.","journal-title":"Genome Res"},{"issue":"11","key":"8640_CR30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1158\/1940-6207.CAPR-14-0129","volume":"7","author":"JP Zackular","year":"2014","unstructured":"Zackular JP, Rogers MAM, Ruffin MT, Schloss PD. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res. 2014;7(11):1112\u201321. https:\/\/doi.org\/10.1158\/1940-6207.CAPR-14-0129.","journal-title":"Cancer Prev Res"},{"issue":"9","key":"8640_CR31","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1373\/clinchem.2018.289728","volume":"64","author":"S Guo","year":"2018","unstructured":"Guo S, Li L, Xu B, Li M, Zeng Q, Xiao H, et al. A simple and novel fecal biomarker for colorectal cancer: ratio of Fusobacterium nucleatum to probiotics populations, based on their antagonistic effect. Clin Chem. 2018;64(9):1327\u201337. https:\/\/doi.org\/10.1373\/clinchem.2018.289728.","journal-title":"Clin Chem"},{"issue":"8","key":"8640_CR32","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.1158\/1078-0432.CCR-16-1599","volume":"23","author":"Q Liang","year":"2017","unstructured":"Liang Q, Chiu J, Chen Y, Huang Y, Higashimori A, Fang J, et al. Fecal bacteria act as novel biomarkers for noninvasive diagnosis of colorectal cancer. Clin Cancer Res. 2017;23(8):2061\u201370. https:\/\/doi.org\/10.1158\/1078-0432.CCR-16-1599.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"8640_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13073-016-0290-3","volume":"8","author":"NT Baxter","year":"2016","unstructured":"Baxter NT, Ruffin MT, Rogers MAM, Schloss PD. Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions. Genome Med. 2016;8(1):1\u201310. https:\/\/doi.org\/10.1186\/s13073-016-0290-3. .","journal-title":"Genome Med"},{"issue":"11","key":"8640_CR34","doi-asserted-by":"publisher","first-page":"766","DOI":"10.15252\/msb.20145645","volume":"10","author":"G Zeller","year":"2014","unstructured":"Zeller G, Tap J, Voigt AY, Sunagawa S, Kultima JR, Costea PI, et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol. 2014;10(11):766. https:\/\/doi.org\/10.15252\/msb.20145645.","journal-title":"Mol Syst Biol"},{"issue":"24","key":"8640_CR35","doi-asserted-by":"publisher","first-page":"1907","DOI":"10.1093\/jnci\/djt300","volume":"105","author":"J Ahn","year":"2013","unstructured":"Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst. 2013;105(24):1907\u201311. https:\/\/doi.org\/10.1093\/jnci\/djt300.","journal-title":"J Natl Cancer Inst"},{"key":"8640_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0155362","volume":"11","author":"E Vogtmann","year":"2016","unstructured":"Vogtmann E, Hua X, Zeller G, Sunagawa S, Voigt AY, Hercog R, et al. Colorectal cancer and the human gut microbiome: reproducibility with whole-genome shotgun sequencing. PLoS One. 2016;11:1\u201313.","journal-title":"PLoS One"},{"key":"8640_CR37","doi-asserted-by":"publisher","unstructured":"Feng Q, Liang S, Jia H, Stadlmayr A, Tang L, Lan Z, et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun. 2015;6(1). https:\/\/doi.org\/10.1038\/ncomms7528.","DOI":"10.1038\/ncomms7528"},{"issue":"1","key":"8640_CR38","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1136\/gutjnl-2015-309800","volume":"66","author":"J Yu","year":"2017","unstructured":"Yu J, Feng Q, Wong SH, Zhang D, Yi Liang Q, Qin Y, et al. Metagenomic analysis of faecal microbiome as a tool towards targeted non-invasive biomarkers for colorectal cancer. Gut. 2017;66(1):70\u20138. https:\/\/doi.org\/10.1136\/gutjnl-2015-309800.","journal-title":"Gut."},{"issue":"1","key":"8640_CR39","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1158\/1055-9965.EPI-16-0337","volume":"26","author":"VL Hale","year":"2017","unstructured":"Hale VL, Chen J, Johnson S, Harrington SC, Yab TC, Smyrk TC, et al. Shifts in the fecal microbiota associated with adenomatous polyps. Cancer Epidemiol Biomark Prev. 2017;26(1):85\u201394. https:\/\/doi.org\/10.1158\/1055-9965.EPI-16-0337.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"8640_CR40","doi-asserted-by":"crossref","unstructured":"Rothschild D, Weissbrod O, Barkan E, Kurilshikov A, Korem T, Zeevi D, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature Publishing Group; 2018;","DOI":"10.1101\/150540"},{"issue":"2","key":"8640_CR41","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1053\/j.gastro.2019.06.048","volume":"158","author":"M Song","year":"2020","unstructured":"Song M, Chan AT, Sun J. Influence of the gut microbiome, diet, and environment on risk of colorectal Cancer. Gastroenterology. 2020;158(2):322\u201340. https:\/\/doi.org\/10.1053\/j.gastro.2019.06.048. .","journal-title":"Gastroenterology."},{"key":"8640_CR42","doi-asserted-by":"publisher","unstructured":"Song M, Chan AT. Environmental Factors, Gut Microbiota, and Colorectal Cancer Prevention. Clinical Gastroenterology and Hepatology. Am Gastroenterological Association; 2019. 275\u2013289 p. https:\/\/doi.org\/10.1016\/j.cgh.2018.07.012. .","DOI":"10.1016\/j.cgh.2018.07.012"},{"issue":"9","key":"8640_CR43","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1136\/gutjnl-2019-318556","volume":"68","author":"AJ Scott","year":"2019","unstructured":"Scott AJ, Alexander JL, Merrifield CA, Cunningham D, Jobin C, Brown R, et al. International Cancer microbiome consortium consensus statement on the role of the human microbiome in carcinogenesis. Gut. 2019;68(9):1624\u201332. https:\/\/doi.org\/10.1136\/gutjnl-2019-318556.","journal-title":"Gut."},{"issue":"4","key":"8640_CR44","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/s41591-019-0405-7","volume":"25","author":"AM Thomas","year":"2019","unstructured":"Thomas AM, Manghi P, Asnicar F, Pasolli E, Armanini F, Zolfo M, et al. Metagenomic analysis of colorectal cancer datasets identifies cross-cohort microbial diagnostic signatures and a link with choline degradation. Nat Med. 2019;25(4):667\u201378. https:\/\/doi.org\/10.1038\/s41591-019-0405-7. .","journal-title":"Nat Med"},{"issue":"4","key":"8640_CR45","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-019-0406-6","volume":"25","author":"J Wirbel","year":"2019","unstructured":"Wirbel J, Pyl PT, Kartal E, Zych K, Kashani A, Milanese A, et al. Meta-analysis of fecal metagenomes reveals global microbial signatures that are specific for colorectal cancer. Nat Med. 2019;25(4):679\u201389. https:\/\/doi.org\/10.1038\/s41591-019-0406-6. .","journal-title":"Nat Med"},{"key":"8640_CR46","volume-title":"Colorectal cancer screening with repeated fecal immunochemical test versus sigmoidoscopy: baseline results from a randomized trial","author":"KR Randel","year":"2020","unstructured":"Randel KR, Schult AL, Botteri E, Hoff G, Bretthauer M, Ursin G, et al. Colorectal cancer screening with repeated fecal immunochemical test versus sigmoidoscopy: baseline results from a randomized trial. United States: Gastroenterology; 2020."},{"key":"8640_CR47","unstructured":"Norwegian Institute of Public Health (NIPH). Norwegian Prescription Database (NorPD). https:\/\/www.fhi.no\/en\/hn\/health-registries\/norpd\/. Accessed 5 November 2020."},{"key":"8640_CR48","unstructured":"Cancer Registry of Norway. Cancer in Norway 2019 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo; 2020."},{"key":"8640_CR49","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1371\/journal.pmed.0040297","volume":"4","author":"JP Vandenbroucke","year":"2007","unstructured":"Vandenbroucke JP, Von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med. 2007;4:1628\u201354.","journal-title":"PLoS Med"},{"issue":"12","key":"8640_CR50","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1016\/j.ijsu.2014.07.014","volume":"12","author":"JP Vandenbroucke","year":"2014","unstructured":"Vandenbroucke JP, von Elm E, Altman DG, G\u00f8tzsche PC, Mulrow CD, Pocock SJ, et al. Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. Int J Surg. 2014;12(12):1500\u201324. https:\/\/doi.org\/10.1016\/j.ijsu.2014.07.014.","journal-title":"Int J Surg"},{"issue":"10","key":"8640_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1473-3099(20)30199-7","volume":"3099","author":"T Bharucha","year":"2020","unstructured":"Bharucha T, Oeser C, Balloux F, Brown JR, Carbo EC, Charlett A, et al. STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies. Lancet Infect Dis. 2020;3099(10):1\u201310. https:\/\/doi.org\/10.1016\/S1473-3099(20)30199-7.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"8640_CR52","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1055\/s-0033-1344548","volume":"45","author":"C Hassan","year":"2013","unstructured":"Hassan C, Quintero E, Dumonceau JM, Regula J, Brand\u00e3o C, Chaussade S, et al. Post-polypectomy colonoscopy surveillance: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2013;45(10):842\u201351. https:\/\/doi.org\/10.1055\/s-0033-1344548.","journal-title":"Endoscopy."},{"key":"8640_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-018-0896-6","volume":"18","author":"TB Rounge","year":"2018","unstructured":"Rounge TB, Meisal R, Nordby JI, Ambur OH, De Lange T, Hoff G. Evaluating gut microbiota profiles from archived fecal samples. BMC Gastroenterol. 2018;18:1\u201311.","journal-title":"BMC Gastroenterol"},{"key":"8640_CR54","unstructured":"University of Oslo (UiO). About TSD. https:\/\/www.uio.no\/english\/services\/it\/research\/sensitive-data\/about\/index.html. Accessed 14 December 2020."},{"issue":"20","key":"8640_CR55","doi-asserted-by":"publisher","first-page":"3600","DOI":"10.1093\/bioinformatics\/bty350","volume":"34","author":"J K\u00f6ster","year":"2018","unstructured":"K\u00f6ster J, Rahmann S. Snakemake - a scalable bioinformatics workflow engine. Bioinformatics. 2018;34(20):3600. https:\/\/doi.org\/10.1093\/bioinformatics\/bty350.","journal-title":"Bioinformatics."},{"issue":"15","key":"8640_CR56","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114\u201320. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170.","journal-title":"Bioinformatics."},{"issue":"4","key":"8640_CR57","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with bowtie 2. Nat Methods. 2012;9(4):357\u20139. https:\/\/doi.org\/10.1038\/nmeth.1923.","journal-title":"Nat Methods"},{"issue":"19","key":"8640_CR58","doi-asserted-by":"publisher","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","volume":"32","author":"P Ewels","year":"2016","unstructured":"Ewels P, Magnusson M, Lundin S, K\u00e4ller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/btw354.","journal-title":"Bioinformatics."},{"issue":"1","key":"8640_CR59","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/oxfordjournals.aje.a009921","volume":"150","author":"LF Andersen","year":"1999","unstructured":"Andersen LF, Solvoll K, Johansson LRK, Salminen I, Aro A, Drevon CA. Evaluation of a food frequency questionnaire with weighed records, fatty acids, and alpha-tocopherol in adipose tissue and serum. Am J Epidemiol. 1999;150(1):75\u201387. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a009921.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"8640_CR60","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1038\/sj.ejcn.1601519","volume":"57","author":"LF Andersen","year":"2003","unstructured":"Andersen LF, Tomten H, Haggarty P, L\u00f8v\u00f8 A, Hustvedt BE. Validation of energy intake estimated from a food frequency questionnaire: a doubly labelled water study. Eur J Clin Nutr. 2003;57(2):279\u201384. https:\/\/doi.org\/10.1038\/sj.ejcn.1601519.","journal-title":"Eur J Clin Nutr"},{"key":"8640_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2891-9-1","volume":"9","author":"MH Carlsen","year":"2010","unstructured":"Carlsen MH, Lillegaard IT, Karlsen A, Blomhoff R, Drevon CA, Andersen LF. Evaluation of energy and dietary intake estimates from a food frequency questionnaire using independent energy expenditure measurement and weighed food records. Nutr J. 2010;9:1\u20139.","journal-title":"Nutr J"},{"issue":"4","key":"8640_CR62","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1079\/BJN20041381","volume":"93","author":"LF Andersen","year":"2005","unstructured":"Andersen LF, Veier\u00f8d MB, Johansson L, Sakhi A, Solvoll K, Drevon CA. Evaluation of three dietary assessment methods and serum biomarkers as measures of fruit and vegetable intake, using the method of triads. Br J Nutr. 2005;93(4):519\u201327. https:\/\/doi.org\/10.1079\/BJN20041381.","journal-title":"Br J Nutr"},{"issue":"10","key":"8640_CR63","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1017\/S0007114510005246","volume":"105","author":"MH Carlsen","year":"2011","unstructured":"Carlsen MH, Karlsen A, Lillegaard ITL, Gran JM, Drevon CA, Blomhoff R, et al. Relative validity of fruit and vegetable intake estimated from an FFQ, using carotenoid and flavonoid biomarkers and the method of triads. Br J Nutr. 2011;105(10):1530\u20138. https:\/\/doi.org\/10.1017\/S0007114510005246.","journal-title":"Br J Nutr"},{"key":"8640_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12937-018-0402-6","volume":"17","author":"SH Brunvoll","year":"2018","unstructured":"Brunvoll SH, Thune I, Frydenberg H, Flote VG, Bertheussen GF, Schlichting E, et al. Validation of repeated self-reported n-3 PUFA intake using serum phospholipid fatty acids as a biomarker in breast cancer patients during treatment. Nutr J. 2018;17:1\u201312.","journal-title":"Nutr J"},{"key":"8640_CR65","unstructured":"Norwegian Food Safety Authority. Norwegian Food Composition Database 2019 [Internet]. Available from: www.matvaretabellen.no. ."},{"issue":"3","key":"8640_CR66","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1079\/PHN2001315","volume":"5","author":"I Johansson","year":"2002","unstructured":"Johansson I, Hallmans G, Wikman \u00c5, Biessy C, Riboli E, Kaaks R. Validation and calibration of food-frequency questionnaire measurements in the northern Sweden health and disease cohort. Public Health Nutr. 2002;5(3):487\u201396. https:\/\/doi.org\/10.1079\/PHN2001315.","journal-title":"Public Health Nutr"},{"issue":"2","key":"8640_CR67","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/ije\/25.2.235","volume":"25","author":"L Holmberg","year":"1996","unstructured":"Holmberg L, Ohlander EM, Byers T, Zack M, Wolk A, Bruce \u00c5, et al. A search for recall Bias in a case-control study of diet and breast Cancer. Int J Epidemiol. 1996;25(2):235\u201344. https:\/\/doi.org\/10.1093\/ije\/25.2.235.","journal-title":"Int J Epidemiol"},{"key":"8640_CR68","volume-title":"Nutritional epidemiology. Oxford","author":"W Willett","year":"2013","unstructured":"Willett W. Nutritional epidemiology. Oxford. New York: Oxford University Press; 2013."},{"key":"8640_CR69","unstructured":"World Cancer Research Fund\/American Institute for Cancer Research. Diet, nutrition, physical activity and colorectal cancer. Continuous Update Project. 2018. https:\/\/www.wcrf.org\/sites\/default\/files\/Colorectal-cancer-report.pdf%0Ahttps:\/\/www.wcrf.org\/sites\/default\/files\/Oesophageal-cancer-report.pdf. Accessed 8 June 2021."},{"issue":"7","key":"8640_CR70","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.3390\/nu11071572","volume":"11","author":"MM Shams-White","year":"2019","unstructured":"Shams-White MM, Brockton NT, Mitrou P, Romaguera D, Brown S, Bender A, et al. Operationalizing the 2018 World Cancer Research Fund\/American Institute for Cancer Research (WCRF\/AICR) Cancer prevention recommendations: a standardized scoring system. Nutrients. 2019;11(7):1572. https:\/\/doi.org\/10.3390\/nu11071572.","journal-title":"Nutrients."},{"issue":"11","key":"8640_CR71","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1017\/S1368980015003547","volume":"19","author":"MS Markussen","year":"2016","unstructured":"Markussen MS, Veierod MB, Kristiansen AL, Ursin G, Andersen LF. Dietary patterns of women aged 50-69 years and associations with nutrient intake, sociodemographic factors and key risk factors for non-communicable diseases. Public Health Nutr. 2016;19(11):2024\u201332. https:\/\/doi.org\/10.1017\/S1368980015003547.","journal-title":"Public Health Nutr"},{"issue":"4","key":"8640_CR72","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/bjc.2017.189","volume":"117","author":"MD Knudsen","year":"2017","unstructured":"Knudsen MD, Berstad P, Hjart\u00e5ker A, Gulichsen EH, Hoff G, De Lange T, et al. Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening. Br J Cancer. 2017;117(4):461\u20139. https:\/\/doi.org\/10.1038\/bjc.2017.189.","journal-title":"Br J Cancer"},{"key":"8640_CR73","unstructured":"Folkehelseinstituttet. Reseptregisteret 2012-2016. 2017."},{"key":"8640_CR74","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. Structure and principles https:\/\/www.whocc.no\/atc\/structure_and_principles\/. Accessed 28 September 2020."},{"key":"8640_CR75","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC\/DDD Index 2020 https:\/\/www.whocc.no\/atc_ddd_index\/. Accessed 28 September 2020."},{"key":"8640_CR76","unstructured":"Cancer Registry of Norway. Cancer in Norway 2018 - Cancer incidence, mortality, survival and prevalence in Norway. Oslo; 2019."},{"issue":"7","key":"8640_CR77","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1016\/j.ejca.2008.10.037","volume":"45","author":"IK Larsen","year":"2009","unstructured":"Larsen IK, Smastuen M, Johannesen TB, Langmark F, Parkin DM, Bray F, et al. Data quality at the Cancer registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer England. 2009;45(7):1218\u201331. https:\/\/doi.org\/10.1016\/j.ejca.2008.10.037.","journal-title":"Eur J Cancer England"},{"key":"8640_CR78","unstructured":"Norwegian Institute of Public Health (NIPH). Access to data from the Norwegian Prescription Database. https:\/\/www.fhi.no\/en\/hn\/health-registries\/norpd\/Access-data-norpd\/#legal-requirements-for-the-disclosure-of-data-from-the-norpd. Accessed 19 June 2020."},{"key":"8640_CR79","unstructured":"Cancer Registry of Norway. The microbiome as a colorectal cancer screening biomarker. https:\/\/www.kreftregisteret.no\/en\/Research\/Projects\/microbiota-and-lifestyle-in-colorectal-cancer-screeing\/. Accessed 29 September 2020."},{"key":"8640_CR80","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.2517-6161.1996.tb02080.x","volume":"58","author":"R Tibshirani","year":"1996","unstructured":"Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc Ser B. 1996;58:267\u201388.","journal-title":"J R Stat Soc Ser B"},{"key":"8640_CR81","doi-asserted-by":"crossref","unstructured":"Cortes C, Vapnik V. Support-vector networks. Mach Learn. 1995;","DOI":"10.1007\/BF00994018"},{"key":"8640_CR82","unstructured":"Breiman L. Random forests. Mach Learn. 2001:1\u2013122."},{"key":"8640_CR83","unstructured":"Haykin S. Neural networks and learning machines. Third Edit. Pearson Prentice Hall; 2009."},{"key":"8640_CR84","doi-asserted-by":"crossref","unstructured":"Chen T, Guestrin C. XGBoost: A Scalable Tree Boosting System. Proc 22nd ACM SIGKDD Int Conf Knowl Discov Data Min. 2016;","DOI":"10.1145\/2939672.2939785"},{"key":"8640_CR85","doi-asserted-by":"crossref","unstructured":"Stark M, Zapf A. Sample size calculation and re-estimation based on the prevalence in a single-arm confirmatory diagnostic accuracy study. Stat Methods Med Res. 2020;","DOI":"10.1177\/0962280220913588"},{"key":"8640_CR86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-018-37186-2","volume":"9","author":"N Nagata","year":"2019","unstructured":"Nagata N, Tohya M, Fukuda S, Suda W, Nishijima S, Takeuchi F, et al. Effects of bowel preparation on the human gut microbiome and metabolome. Sci Rep. 2019;9:1\u20138.","journal-title":"Sci Rep"},{"issue":"9","key":"8640_CR87","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1002\/1097-0142(19900501)63:9<1826::aid-cncr2820630928>3.0.co;2-p","volume":"63","author":"DA Ahlquist","year":"1989","unstructured":"Ahlquist DA, McGill DB, Fleming JL, Schwartz S, Wieand HS, Rubin J, et al. Patterns of occult bleeding in asymptomatic colorectal cancer. Cancer. 1989;63(9):1826\u201330. https:\/\/doi.org\/10.1002\/1097-0142(19900501)63:9<1826::aid-cncr2820630928>3.0.co;2-p.","journal-title":"Cancer."},{"key":"8640_CR88","unstructured":"Hannelore D. Diet and the gut microbiome: from hype to hypothesis. Br J Nutr. 2020:1\u201324."},{"issue":"8","key":"8640_CR89","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/gutjnl-2014-307376","volume":"64","author":"P Berstad","year":"2015","unstructured":"Berstad P, L\u00f8berg M, Larsen IK, Kalager M, Holme \u00d8, Botteri E, et al. Long-term lifestyle changes after colorectal cancer screening: randomised controlled trial. Gut. 2015;64(8):1268\u201376. https:\/\/doi.org\/10.1136\/gutjnl-2014-307376.","journal-title":"Gut."},{"issue":"4","key":"8640_CR90","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1097\/CEJ.0000000000000328","volume":"27","author":"MD Knudsen","year":"2018","unstructured":"Knudsen MD, Hjart\u00e5ker A, Olsen MKE, Hoff G, De Lange T, Bernklev T, et al. Changes in health behavior 1 year after testing negative at a colorectal cancer screening: a randomized-controlled study. Eur J Cancer Prev. 2018;27(4):316\u201322. https:\/\/doi.org\/10.1097\/CEJ.0000000000000328.","journal-title":"Eur J Cancer Prev"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08640-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-021-08640-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-021-08640-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T15:50:58Z","timestamp":1725637858000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-021-08640-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,18]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["8640"],"URL":"https:\/\/doi.org\/10.1186\/s12885-021-08640-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.12.22.20248658","asserted-by":"object"}]},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,18]]},"assertion":[{"value":"16 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The CRCbiome study is approved by the Norwegian Regional Committees for Medical and Health Research Ethics (Approval no.: 63148). Returning at least one of the two questionnaires sent out to potential study participants at baseline is regarded as a consent to the study, and includes permission to collect, analyze and store fecal samples, and to retrieve information from questionnaires and health registries. All biological materials are stored in a biobank at Oslo University Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"930"}}